Cencora Price to Sales Ratio 2010-2024 | COR
Historical PS ratio values for Cencora (COR) over the last 10 years. The current P/S ratio for Cencora as of November 05, 2024 is .
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
| Cencora P/S Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Sales per Share | Price to Sales Ratio |
| 2024-11-05 | 233.99 | 0.17 | |
| 2024-06-30 | 224.82 | $1,406.04 | 0.16 |
| 2024-03-31 | 241.92 | $1,362.49 | 0.18 |
| 2023-12-31 | 204.02 | $1,333.10 | 0.15 |
| 2023-09-30 | 178.32 | $1,279.72 | 0.14 |
| 2023-06-30 | 190.17 | $1,232.48 | 0.15 |
| 2023-03-31 | 157.79 | $1,188.58 | 0.13 |
| 2022-12-31 | 162.80 | $1,150.18 | 0.14 |
| 2022-09-30 | 132.54 | $1,127.96 | 0.12 |
| 2022-06-30 | 138.14 | $1,120.92 | 0.12 |
| 2022-03-31 | 150.60 | $1,092.89 | 0.14 |
| 2021-12-31 | 128.94 | $1,057.71 | 0.12 |
| 2021-09-30 | 115.47 | $1,029.28 | 0.11 |
| 2021-06-30 | 110.27 | $987.16 | 0.11 |
| 2021-03-31 | 113.29 | $952.23 | 0.12 |
| 2020-12-31 | 93.41 | $944.14 | 0.10 |
| 2020-09-30 | 92.23 | $920.85 | 0.10 |
| 2020-06-30 | 95.51 | $895.81 | 0.11 |
| 2020-03-31 | 83.47 | $889.33 | 0.09 |
| 2019-12-31 | 79.83 | $864.13 | 0.09 |
| 2019-09-30 | 76.96 | $845.62 | 0.09 |
| 2019-06-30 | 79.33 | $826.69 | 0.10 |
| 2019-03-31 | 73.61 | $807.87 | 0.09 |
| 2018-12-31 | 68.56 | $788.66 | 0.09 |
| 2018-09-30 | 84.60 | $759.77 | 0.11 |
| 2018-06-30 | 77.88 | $739.80 | 0.11 |
| 2018-03-31 | 78.39 | $718.83 | 0.11 |
| 2017-12-31 | 83.17 | $702.16 | 0.12 |
| 2017-09-30 | 74.60 | $690.86 | 0.11 |
| 2017-06-30 | 84.83 | $680.55 | 0.12 |
| 2017-03-31 | 79.09 | $670.16 | 0.12 |
| 2016-12-31 | 69.59 | $660.58 | 0.11 |
| 2016-09-30 | 71.57 | $650.55 | 0.11 |
| 2016-06-30 | 70.01 | $647.19 | 0.11 |
| 2016-03-31 | 76.05 | $625.63 | 0.12 |
| 2015-12-31 | 90.77 | $615.62 | 0.15 |
| 2015-09-30 | 82.84 | $606.75 | 0.14 |
| 2015-06-30 | 92.49 | $578.08 | 0.16 |
| 2015-03-31 | 98.61 | $570.02 | 0.17 |
| 2014-12-31 | 77.99 | $542.13 | 0.14 |
| 2014-09-30 | 66.65 | $512.17 | 0.13 |
| 2014-06-30 | 62.46 | $481.96 | 0.13 |
| 2014-03-31 | 56.18 | $440.47 | 0.13 |
| 2013-12-31 | 60.02 | $407.52 | 0.15 |
| 2013-09-30 | 51.98 | $373.65 | 0.14 |
| 2013-06-30 | 47.15 | $342.60 | 0.14 |
| 2013-03-31 | 43.28 | $325.23 | 0.13 |
| 2012-12-31 | 36.16 | $312.86 | 0.12 |
| 2012-09-30 | 32.25 | $300.82 | 0.11 |
| 2012-06-30 | 32.67 | $295.91 | 0.11 |
| 2012-03-31 | 32.81 | $292.59 | 0.11 |
| 2011-12-31 | 30.66 | $288.10 | 0.11 |
| 2011-09-30 | 30.62 | $281.75 | 0.11 |
| 2011-06-30 | 33.91 | $281.76 | 0.12 |
| 2011-03-31 | 32.31 | $277.88 | 0.12 |
| 2010-12-31 | 27.79 | $274.46 | 0.10 |
| 2010-09-30 | 24.89 | $269.98 | 0.09 |
| 2010-06-30 | 25.71 | $263.79 | 0.10 |
| 2010-03-31 | 23.36 | $256.60 | 0.09 |
| 2009-12-31 | 20.99 | $246.23 | 0.09 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $46.107B | $262.173B |
| CENCORA INC is a healthcare solutions provider. CENCORA INC., formerly known as AmerisourceBergen, is based in CONSHOHOCKEN, Pa. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $96.890B | 12.02 |
| DiDi Global (DIDIY) | China | $23.233B | 0.00 |
| ICON (ICLR) | Ireland | $18.679B | 16.64 |
| Revvity (RVTY) | United States | $15.535B | 26.63 |
| Avantor (AVTR) | United States | $15.498B | 23.24 |
| Natera (NTRA) | United States | $15.385B | 0.00 |
| Viatris (VTRS) | United States | $13.858B | 4.22 |
| BioMerieux (BMXMF) | France | $13.601B | 0.00 |
| Solventum (SOLV) | United States | $12.636B | 0.00 |
| CochLear (CHEOY) | Australia | $12.565B | 0.00 |
| Medpace Holdings (MEDP) | United States | $10.202B | 28.74 |
| Charles River Laboratories (CRL) | United States | $9.742B | 18.41 |
| Sonic Healthcare (SKHHY) | Australia | $8.273B | 0.00 |
| HealthEquity (HQY) | United States | $7.792B | 42.29 |
| Doximity (DOCS) | United States | $7.787B | 49.34 |
| Bausch + Lomb (BLCO) | Canada | $6.975B | 32.47 |
| Life Times (LTH) | United States | $4.762B | 31.52 |
| PACS (PACS) | United States | $4.502B | 0.00 |
| Sotera Health (SHC) | United States | $4.367B | 23.36 |
| Organon (OGN) | United States | $4.239B | 4.28 |
| Surgery Partners (SGRY) | United States | $3.778B | 41.86 |
| BrightSpring Health Services (BTSG) | United States | $3.070B | 65.30 |
| Ardent Health Partners (ARDT) | United States | $2.577B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $2.546B | 0.00 |
| Concentras Parent (CON) | United States | $2.480B | 0.00 |
| Premier (PINC) | United States | $2.271B | 11.34 |
| GoodRx Holdings (GDRX) | United States | $2.254B | 84.86 |
| GeneDx Holdings (WGS) | United States | $2.057B | 0.00 |
| Ryman Healthcare (RYHTY) | New Zealand | $2.036B | 0.00 |
| Teladoc Health (TDOC) | United States | $1.575B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $1.507B | 7.57 |
| Progyny (PGNY) | United States | $1.425B | 25.06 |
| Establishment Labs Holdings (ESTA) | $1.338B | 0.00 | |
| Pediatrix Medical (MD) | United States | $1.319B | 12.91 |
| CareDx (CDNA) | United States | $1.228B | 0.00 |
| Agilon Health (AGL) | United States | $1.123B | 0.00 |
| Embecta (EMBC) | United States | $0.864B | 5.76 |
| InnovAge Holding (INNV) | United States | $0.822B | 0.00 |
| QDM (QDMI) | Hong Kong, SAR China | $0.790B | 20.69 |
| SBC Medicals (SBC) | United States | $0.722B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.488B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.483B | 0.00 |
| Enhabit (EHAB) | United States | $0.382B | 33.04 |
| DocGo (DCGO) | United States | $0.355B | 13.35 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.309B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.255B | 0.00 |
| ModivCare (MODV) | United States | $0.232B | 7.37 |
| Beauty Health (SKIN) | United States | $0.211B | 0.00 |
| Biodesix (BDSX) | United States | $0.195B | 0.00 |
| LifeMD (LFMD) | United States | $0.192B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.178B | 0.00 |
| MultiPlan (MPLN) | United States | $0.136B | 0.00 |
| Nutex Health (NUTX) | United States | $0.127B | 0.00 |
| So-Young (SY) | China | $0.092B | 22.35 |
| Harvard Apparatus Regenerative Technology (HRGN) | United States | $0.059B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.057B | 0.00 |
| OncoCyte (OCX) | United States | $0.049B | 0.00 |
| NeueHealth (NEUE) | United States | $0.041B | 1.63 |
| Co-Diagnostics (CODX) | United States | $0.039B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.036B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.027B | 0.00 |
| Pheton Holdings (PTHL) | China | $0.027B | 0.00 |
| Oncology Institute (TOI) | United States | $0.021B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.012B | 0.00 |
| XWELL (XWEL) | United States | $0.009B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.007B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.007B | 0.00 | |
| KindlyMD (KDLY) | United States | $0.005B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |
| Cano Health (CANOQ) | United States | $0.001B | 0.00 |